Clinical Trial Update: Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dose modification of efavirenz based on blood concentration in HIV patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV | Phase 4 | Status: COMPLETED